Md Wahiduzzaman

7PUBLICATIONS
14CO-AUTHORS
Molecular targetsNanoscale characterisationMajor global burdens of diseaseMedical infection agents (incl. prions)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 23, 2026
Nintedanib inhibits the VEGFR-ERK signaling pathway in human KRAS-mutated cancer cells.

|Jun 04, 2026
NgBR controls hepatic adiponectin signaling competence through KAT7-dependent chromatin regulation.

|Mar 01, 2026
Targeting fatty acid synthase suppresses tumor development in NF2/CDKN2A-deficient pleural mesothelioma.

Sivasundaram Karnan, Akinobu Ota, Muhammad Nazmul Hasan

|Oct 10, 2024
FerroEnrich: An Interactive web tool for computing Ferroptosis index and gene enrichment.

Munichandra Babu Tirumalasetty, Mayank Choubey, Md Wahiduzzaman

|Jan 28, 2024
ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cells.

Sivasundaram Karnan, Ichiro Hanamura, Akinobu Ota

|Jul 21, 2023
CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma.

Sivasundaram Karnan, Akinobu Ota, Hideki Murakami

Pageof 2

Frequent Collaborators

5 joint publications

Akinobu Ota

5 joint publications

Sivasundaram Karnan

5 joint publications

Hiroyuki Konishi

4 joint publications

Muhammad Nazmul Hasan